“…IPF is one of the late outcomes of lung diseases, induced by a variety of causes, that is characterized by destruction of the alveolar histoarchitecture, excessive accumulation of extracellular matrix, infiltration of immunocytes, and irregular changes in fibroblasts (Martinez et al, 2017). As a chronic, progressive, fibrosing form of interstitial pneumonia, IPF reduced human survival, which has been historically approximately 50% with an average survival duration of fewer than 5 years (Bargagli et al, 2019; Lancet, 2015). Studies have suggested that the EMT (epithelial‐mesenchymal transformation) process, characterized by loss of epithelial markers and gain of mesenchymal markers, might account for the occurrence of fibrosis (Qian, Lin, Zhao, Wang, & Liu, 2018; Zhang et al, 2018).…”